InvestorsObserver
×
News Home

Where Does Immatics NV (IMTX) Stock Fall in the Biotechnology Field After It Is Down -3.11% This Week?

Thursday, September 14, 2023 12:34 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Immatics NV (IMTX) Stock Fall in the Biotechnology Field After It Is Down -3.11% This Week?

A rating of 86 puts Immatics NV (IMTX) near the top of the Biotechnology industry according to InvestorsObserver. Immatics NV's score of 86 means it scores higher than 86% of stocks in the industry. Immatics NV also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 67 out of the 148 industries.

Overall Score - 64
IMTX has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on IMTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Immatics NV Stock Today?

Immatics NV (IMTX) stock is trading at $12.15 as of 12:33 PM on Thursday, Sep 14, an increase of $0.28, or 2.36% from the previous closing price of $11.87. The stock has traded between $11.83 and $12.77 so far today. Volume today is 251,624 compared to average volume of 276,517. Click Here to get the full Stock Report for Immatics NV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App